Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions (NCT03160274)
🩺 Plain-English Summary (8th-Grade Level)
Pheochromocytomas and paragangliomas are neural crest-derived tumors of the nervous system that are often inherited and genetically heterogeneous. Genetic screening is recommended for patients and their relatives, and can guide clinical decisions. However, a mutation is not found in all cases. The aims of this proposal are to: 1) to map gene(s) involved in pheochromocytoma, and 2) identify genotype-phenotype correlations in patients with pheochromocytoma/paraganglioma of various genetic origins.
Who can join: Review the eligibility criteria below.
Location: University of Texas Health Science Center — San Antonio, Texas
🧪 Interventions in This Study
- Genetic screening (GENETIC)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Texas Health Science Center — San Antonio, Texas
📞 Contact the Study Coordinator
Phone: (210) 567-4866
Email: dahia@uthscsa.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pheochromocytoma
- Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma — New York, New York
- Zanzalintinib in Unresectable and Progressive MPGGs — Boston, Massachusetts
- 211At-MABG in Adults With Advanced Neuroendocrine Cancers — Philadelphia, Pennsylvania
- Diagnosis of Pheochromocytoma — Bethesda, Maryland
- Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma — Bethesda, Maryland
Explore by condition: All Pheochromocytoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.